tetano
Editor, Senior Moderator
Clin Pract Cases Emerg Med
. 2020 Aug;4(3):332-335.
doi: 10.5811/cpcem.2020.6.47856.
Cardioembolic Stroke in a Patient with Coronavirus Disease of 2019 (COVID-19) Myocarditis: A Case Report
James S Ford[SUP] 1 [/SUP], James F Holmes[SUP] 1 [/SUP], Russell F Jones[SUP] 1 [/SUP]
Affiliations
Abstract
Introduction: There is a growing body of literature detailing coronavirus 2019 (COVID-19) cardiovascular complications and hypercoagulability, although little has been published on venous or arterial thrombosis risk.
Case report: In this report, we present a single case of cardioembolic stroke in the setting of COVID-19 related myocarditis, diagnosed via cardiac magnetic resonance imaging and echocardiography. COVID-19 infection was confirmed via a ribonucleic acid polymerase chain reaction assay.
Conclusion: Further research is needed to evaluate the hypercoagulable state of patients with COVID-19 to determine whether prophylactic anticoagulation may be warranted to prevent intracardiac thrombi and cardioembolic disease in patients with COVID-19 related myocarditis.
. 2020 Aug;4(3):332-335.
doi: 10.5811/cpcem.2020.6.47856.
Cardioembolic Stroke in a Patient with Coronavirus Disease of 2019 (COVID-19) Myocarditis: A Case Report
James S Ford[SUP] 1 [/SUP], James F Holmes[SUP] 1 [/SUP], Russell F Jones[SUP] 1 [/SUP]
Affiliations
- PMID: 32926679
- DOI: 10.5811/cpcem.2020.6.47856
Abstract
Introduction: There is a growing body of literature detailing coronavirus 2019 (COVID-19) cardiovascular complications and hypercoagulability, although little has been published on venous or arterial thrombosis risk.
Case report: In this report, we present a single case of cardioembolic stroke in the setting of COVID-19 related myocarditis, diagnosed via cardiac magnetic resonance imaging and echocardiography. COVID-19 infection was confirmed via a ribonucleic acid polymerase chain reaction assay.
Conclusion: Further research is needed to evaluate the hypercoagulable state of patients with COVID-19 to determine whether prophylactic anticoagulation may be warranted to prevent intracardiac thrombi and cardioembolic disease in patients with COVID-19 related myocarditis.